Evidence map›Paper›PMID 29740426›Full record

ArticleFrontiers in immunology2018

Multipotent Adult Progenitor Cells Suppress T Cell Activation in

Fiona Carty, Jennifer M Corbett, João Paulo M C M Cunha, James L Reading, Timothy I M Tree, Anthony E Ting, Samantha R Stubblefield, Karen English

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 3 countries.

Fiona CartyDepartment of Biology, Institute of Immunology, Maynooth University, Maynooth, Ireland.
Jennifer M CorbettDepartment of Biology, Institute of Immunology, Maynooth University, Maynooth, Ireland.
João Paulo M C M CunhaDepartment of Biology, Institute of Immunology, Maynooth University, Maynooth, Ireland.
James L ReadingDepartment of Immunobiology, King's College London, London, United Kingdom.
Timothy I M TreeDepartment of Immunobiology, King's College London, London, United Kingdom.
Anthony E TingAthersys Inc., Cleveland, OH, United States.
Samantha R StubblefieldAthersys Inc., Cleveland, OH, United States.
Karen EnglishDepartment of Biology, Institute of Immunology, Maynooth University, Maynooth, Ireland.
National University of Ireland, Maynooth · IEAthersys (United States) · USKing's College London · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lymphodepletion strategies are used in the setting of transplantation (including bone marrow, hematopoietic cell, and solid organ) to create space or to prevent allograft rejection and graft versus host disease. Following lymphodepletion, there is an excess of IL-7 available, and T cells that escape depletion respond to this cytokine undergoing accelerated proliferation. Moreover, this environment promotes the skew of T cells to a Th1 pro-inflammatory phenotype. Existing immunosuppressive regimens fail to control this homeostatic proliferative (HP) response, and thus the development of strategies to successfully control HP while sparing T cell reconstitution (providing a functioning immune system) represents a significant unmet need in patients requiring lymphodepletion. Multipotent adult progenitor cells (MAPC

Indexed as

TransplantationAdult Stem CellsAnimalsCell ProliferationCells, CulturedDinoprostoneDisease Models, AnimalGraft RejectionHomeostasisHumansImmunotherapyLymphocyte ActivationLymphocyte DepletionMiceMice, Inbred C57BLPluripotent Stem CellsDinoprostoneanti-thymocyte globulinhomeostatic proliferationIL-7mesenchymal stromal cellsmultipotent adult progenitor cellsprostaglandin E2

Identifiers

PMID29740426
PMCPMC5925221
OpenAlexW2801619901

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.